Psychoactive "bath salts": Not so soothing

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 1-5

  Baumann, Michael H ^a   Partilla, John S ^a   Lehner, Kurt R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cathinone; Designer drug; Dopamine; Monoamine transporter; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYPYROVALERONE; 4' METHYLMETHCATHINONE; BATH SALTS; CATHINONE; CATHINONE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; ILLICIT DRUG; METHYLONE; NORADRENALIN; NORADRENALIN TRANSPORTER; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ALERTNESS; DELIRIUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG TARGETING; EUPHORIA; EXTRACELLULAR SPACE; GOVERNMENT; HALLUCINATION; HUMAN; HYPERTHERMIA; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; TACHYCARDIA;

EID: 84871923568     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.020     Document Type: Article

References (54)

1. M. Angoa-Perez, M.J. Kane, D.M. Francescutti, K.E. Sykes, M.M. Shah, A.M. Mohammed, D.M. Thomas, and D.M. Kuhn Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum J. Neurochem. 120 2012 1097 1107
2. J.L. Antoniwicz, A.K. Metzger, and S.L. Ramanujam Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases Gen. Hosp. Psychiatry 33 2011 640.e5 640.e6
3. M.H. Baumann, M.A. Ayestas Jr, J.S. Partilla, J.R. Sink, A.T. Shulgin, P.F. Daley, S.D. Brandt, R.B. Rothman, A.E. Ruoho, and N.V. Cozzi The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuropsychopharmacology 37 2012 1192 1203
4. Baumann, M.H., Partilla, J.S., Lehner, K.R., Thorndike, E.B., Hoffman, A.F., Holy, M., Rothman, R.B., Goldberg, S.R., Lupica, C.R., Sitte, H.H., Brandt, S.D., Tella S.R., Cozzi, N.V., Schindler, C.W. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive bath salts products. Neuropsychopharmacology, in press, 10.1038/npp.2012.204
5. M.H. Baumann, X. Wang, and R.B. Rothman 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings Psychopharmacology 189 2007 407 424 (Pubitemid 44791212)
6. H.A. Borek, and C.P. Holstege Hyperthermia and multiorgan failure after abuse of bath salts containing 3,4-methylenedioxypyrovalerone Ann. Emerg. Med. 60 2012 103 105
7. S.D. Brandt, H.R. Sumnall, F. Measham, and J. Cole Analyses of second-generation 'legal highs' in the UK: initial findings Drug Test. Anal. 2 2010 377 382
8. Centers for Disease Control and Prevention (CDC), 2011. Emergency department visits after use of a drug sold as bath salts - Michigan, November 13, 2010 - March 31, 2011. Morbidity and mortality weekly report 60, MMWR, pp. 624-627.
9. M. Coppola, and R. Mondola Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts or plant food Toxicol. Lett. 211 2012 144 149
10. N.V. Cozzi, M.K. Sievert, A.T. Shulgin, P. Jacob 3rd, and A.E. Ruoho Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines Eur. J. Pharmacol. 381 1999 63 69 (Pubitemid 29488590)
11. Drug Enforcement Administration (DEA), 2011. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order. Federal Register 76, pp. 65371-65375.
12. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu. Rev. Pharmacol. Toxicol. 47 2007 681 698
13. R.A. Glennon, M. Yousif, N. Naiman, and P. Kalix Methcathinone: a new and potent amphetamine-like agent Pharmacol. Biochem. Behav. 26 1987 547 551 (Pubitemid 17047729)
14. G.C. Hadlock, K.M. Webb, L.M. McFadden, P.W. Chu, J.D. Ellis, S.C. Allen, D.M. Andrenyak, P.L. Vieira-Brock, C.L. German, K.M. Conrad, A.J. Hoonakker, J.W. Gibb, D.G. Wilkins, G.R. Hanson, and A.E. Fleckenstein 4- Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse J. Pharmacol. Exp. Ther. 339 2011 530 536
15. C. Heron, J. Costentin, and J.J. Bonnet Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier Eur. J. Pharmacol. 264 1994 391 398 (Pubitemid 24335482)
16. L.L. Howell, and H.L. Kimmel Monoamine transporters and psychostimulant addiction Biochem. Pharmacol. 75 2008 196 217 (Pubitemid 350235397)
17. P.K. Huang, S.M. Aarde, D. Angrish, K.L. Houseknecht, T.J. Dickerson, and M.A. Taffe Contrasting effects of d-methamphetamine, 3,4- methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats Drug Alcohol Depend. 126 2012 168 175
18. D. James, R.D. Adams, R. Spears, G. Cooper, D.J. Lupton, J.P. Thompson, and S.H. Thomas Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service Emerg. Med. J. 28 2011 686 689
19. P. Kalix Cathinone, a natural amphetamine Pharmacol. Toxicol. 70 1992 77 86
20. H.T. Kamata, N. Shima, K. Zaitsu, T. Kamata, A. Miki, M. Nishikawa, M. Katagi, and H. Tsuchihashi Metabolism of the recently encountered designer drug, methylone, in humans and rats Xenobiotica 36 2006 709 723 (Pubitemid 44195985)
21. D.P. Kasick, C.A. McKnight, and E. Klisovic Bath salt ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use Am. J. Drug Alcohol Abuse 38 2012 176 180
22. J. Kehr, F. Ichinose, S. Yoshitake, M. Goiny, T. Sievertsson, F. Nyberg, and T. Yoshitake Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats Br. J. Pharmacol. 164 2011 1949 1958
23. P.B. Kyle, R.B. Iverson, R.G. Gajagowni, and L. Spencer Illicit bath salts: not for bathing J. Miss. State Med. Assoc. 52 2011 375 377
24. R. Lisek, W. Xu, E. Yuvasheva, Y.T. Chiu, A.B. Reitz, L.Y. Liu-Chen, and S.M. Rawls Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation Drug Alcohol Depend. 126 2012 257 262
25. R. Lopez-Arnau, J. Martinez-Clemente, D. Pubill, E. Escubedo, and J. Camarasa Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone Br. J. Pharmacol. 167 2012 407 420
26. K.J. Lusthof, R. Oosting, A. Maes, M. Verschraagen, A. Dijkhuizen, and A.G. Sprong A case of extreme agitation and death after the use of mephedrone in The Netherlands Forensic Sci. Int. 206 2011 e93 e95
27. Macher, A.M., Penders, T.M. False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV). Drug testing and analysis, in press, 10.1002/dta.1371.
28. J. Martinez-Clemente, E. Escubedo, D. Pubill, and J. Camarasa Interaction of mephedrone with dopamine and serotonin targets in rats Eur. Neuropsychopharmacol. 22 2012 231 236
29. J.A. Marusich, K.R. Grant, B.E. Blough, and J.L. Wiley Effects of synthetic cathinones contained in bath salts on motor behavior and a functional observation battery in mice Neurotoxicology 33 2012 1305 1313
30. D.C. Mash, L. Duque, J. Pablo, Y. Qin, N. Adi, W.L. Hearn, B.A. Hyma, S.B. Karch, H. Druid, and C.V. Wetli Brain biomarkers for identifying excited delirium as a cause of sudden death Forensic Sci. Int. 190 2009 e13 e19
31. P.D. Maskell, G. De Paoli, C. Seneviratne, and D.J. Pounder Mephedrone (4-methylmethcathinone)-related deaths J. Anal. Toxicol. 35 2011 188 191
32. P.C. Meltzer, D. Butler, J.R. Deschamps, and B.K. Madras 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors J. Med. Chem. 49 2006 1420 1432 (Pubitemid 43271895)
33. M.R. Meyer, P. Du, F. Schuster, and H.H. Maurer Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxypyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS J. Mass Spectrom. 45 2010 1426 1442
34. C.P. Motbey, G.E. Hunt, M.T. Bowen, S. Artiss, and I.S. McGregor Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats Addict. Biol. 17 2012 409 422
35. B.L. Murray, C.M. Murphy, and M.C. Beuhler Death following recreational use of designer drug bath salts containing 3,4-methylenedioxypyrovalerone (MDPV) J. Med. Toxicol. 8 2012 69 75
36. F. Nagai, R. Nonaka, and Satoh Hisashi Kamimura, K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain Eur. J. Pharmacol. 559 2007 132 137 (Pubitemid 46295399)
37. T.M. Penders, R.E. Gestring, and D.A. Vilensky Intoxication delirium following use of synthetic cathinone derivatives Am. J. Drug Alcohol Abuse 38 2012 616 617
38. J.M. Prosser, and L.S. Nelson The toxicology of bath salts: a review of synthetic cathinones J. Med. Toxicol. 8 2012 33 42
39. J.E. Robinson, A.E. Agoglia, E.W. Fish, M.C. Krouse, and C.J. Malanga Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine Behav. Brain Res. 234 2012 76 81
40. C.D. Rosenbaum, S.P. Carreiro, and K.V. Babu Here today, gone tomorrow... and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines J. Med. Toxicol. 8 2012 15 32
41. E.A. Ross, M. Watson, and B. Goldberger Bath salts intoxication N. Engl. J. Med. 365 2011 967 968
42. R.B. Rothman, and M.H. Baumann Monoamine transporters and psychostimulant drugs Eur. J. Pharmacol. 479 2003 23 40 (Pubitemid 37377873)
43. R.B. Rothman, M.H. Baumann, C.M. Dersch, D.V. Romero, K.C. Rice, F.I. Carroll, and J.S. Partilla Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 2001 32 41
44. R.B. Rothman, N. Vu, J.S. Partilla, B.L. Roth, S.J. Hufeisen, B.A. Compton-Toth, J. Birkes, R. Young, and R.A. Glennon In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates J. Pharmacol. Exp. Ther. 307 2003 138 145 (Pubitemid 37151899)
45. A.J. Ruttenber, J. Lawler-Heavner, M. Yin, C.V. Wetli, W.L. Hearn, and D.C. Mash Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity J. Forensic Sci. 42 1997 25 31 (Pubitemid 27023637)
46. F. Schifano, A. Albanese, S. Fergus, J.L. Stair, P. Deluca, O. Corazza, Z. Davey, J. Corkery, H. Siemann, N. Scherbaum, M. Farre, M. Torrens, Z. Demetrovics, A.H. Ghodse, M. Psychonaut Web, and D.R.G. Re Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues Psychopharmacology 214 2011 593 602
47. K.G. Shanks, T. Dahn, G. Behonick, and A. Terrell Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry J. Anal. Toxicol. 36 2012 360 371
48. Simmler, L.D., Buser, T.A., Donzelli, M., Schramm, Y., Dieu, L.H., Huwyler, J., Chaboz, S., Hoener, M.C., Liechti, M.E. Pharmacological characterization of designer cathinones in vitro. British journal of pharmacology, in press, 10.1111/j.1476-5381.2012.02145.x.
49. H.H. Sitte, and M. Freissmuth The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters - why amphetamines take two to tango J. Neurochem. 112 2010 340 355
50. C. Sogawa, N. Sogawa, K. Ohyama, R. Kikura-Hanajiri, Y. Goda, I. Sora, and S. Kitayama Methylone and monoamine transporters: correlation with toxicity Curr. Neuropharmacol. 9 2011 58 62
51. H.A. Spiller, M.L. Ryan, R.G. Weston, and J. Jansen Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States Clin. Toxicol. 49 2011 499 505
52. Watterson, L.R., Kufahl, P.R., Nemirovsky, N.E., Sewalia, K., Grabenauer, M., Thomas, B.F., Marusich, J.A., Wegner, S., Olive, M.F. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addiction biology, in press, 10.111/j.1369-1600.2012.00474.x.
53. R.A. Wise Dopamine and reward: the anhedonia hypothesis 30 years on Neurotox Res 14 2008 169 183
54. M.J. Wright, D. Angrish, S.M. Aarde, D.J. Barlow, M.W. Buczynski, K.M. Creehan, S.A. Vandewater, L.H. Parsons, K.L. Houseknecht, T.J. Dickerson, and M.A. Taffe PLos one 7 2012 e44652